Corixa and Wyeth Lederle Vaccines expand collaboration

CRXA granted Wyeth Lederle expanded access to its monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi ImmunoChem, which CRXA acquired last year. The expansion includes an oil-based ...